North America Automated Cell Cultures Market – Industry Trends and Forecast to 2029

North America Automated Cell Cultures Market Analysis and Insights

The automated cell cultures market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America automated cell cultures market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.1% in the forecast period of 2022 to 2029 and is expected to reach EURO 7,797.02 million by 2029. Increasing demand of cell culture technology in vaccine production, and Wide acceptance of cell culture techniques in various applications are the major drivers which propelled the demand of the market in the forecast period.

North America Automated Cell Cultures Market Definition

Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.

North America Automated Cell Cultures Market Dynamics

This section deals with understanding the market drivers, opportunity, restraint, and challenge. All of this is discussed in detail below:

• Drivers

Increasing Demand for Cell Culture Technology in Vaccine Production

Cell culture is an essential tool for molecular and cellular biology research. Today, most biotechnology products primarily rely on mass culturing cell lines. Cell cultures have applications in diverse areas and serve as a model system for numerous research efforts.

An increase in funding from the government for cell-based research is significantly triggering the market's growth. In addition, cell culture techniques are widely being used as an alternative to current egg-based strategies for developing cell-based vaccines. Cell culture has potential applications in developing viral vaccines with increased communicable diseases and pandemic risk. Thus, cell culture technology is being extensively used in developing U.S. licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio.

Technological Advancements in Cell Culture Technology Systems

As the demand for advanced cell culture technologies in vaccine production, cancer research, and virology, among others, is increasing, certain technological developments are taking place in automated cell culture.

Thus, market players operating in the market adopt various technological developments in cell culture equipment to boost their business in various dimensions and lead to market growth. This factor could drive the North America automated cell cultures market growth.

• Restraint

High Cost of Automated Cell Culture Systems

The cost of the product is the major setback for the market as it is expected to decrease the demand due to high cost. In the case of automated cell culture systems, the price is also high, and below the given instance will showcase the product's price.

The instruments and consumables-related products such as cell counters, reagents, buffers, and others have high prices, which shows that the cost of automated cell cultures is the primary factor expected to restrain the North America automated cell cultures market in the forecasted period.

• Opportunity

New Product Launches and Technology Developments

Pharmaceutical and biotechnology-driven companies are working towards developing and launching new products and technologies for automated cell culture advancement and making the treatment and diagnosis methods more reachable. This has also increased the demand for an automated cell culture market for 3D cell cultures. The development of new bioreactors, platforms, softwares has led to an advancement in the automated cell culture market and its growth.

The new products and technologies launched and worked upon create good opportunities for the North America automated cell cultures market. The new platforms with advanced technologies act as a footstep closer to the advancement of the market.

• Challenge

Development and Maintenance of Expertise            

Recruitment and retention of trained and qualified staff, staff development, capital budgets for equipment purchase, operating budget management, facility infrastructure, and change management all require proper attention for the growth and success of any market. Failure to meet needs in any of these areas can lead to a serious weakness that, if uncorrected, may compromise the credibility of a laboratory and create a situation that will be difficult to correct in the short term.

Testing and maintaining the level of expertise in testing laboratories is a tough task, and it needs high experience, which sometimes is not accessible, which causes the development process for a particular company to hinder. Thus it is anticipated to challenge the North America automated cell cultures market growth in the forecasted period.

Recent Developments

• In August 2021, Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, announced the execution of a definitive agreement to acquire Solentim, a trusted North America leader of solutions for the isolation and characterization of high-value single-cell clones in cell line development (CLD) applications. The acquisition expands both companies' positions in the bioprocess workflows for advanced therapies
• In July 2021, BD has launched bdbiosciences.com, an updated digital marketplace for flow cytometry. The new website provides an enhanced online purchasing experience for flow cytometry users and their procurement teams

North America Automated Cell Cultures Market Scope

North America automated cell cultures market is segmented into Product, Type, Application, and End User. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

North America Automated Cell Cultures Market, By Product

• Consumables
• Instruments

On the basis of product, the North America automated cell cultures market is segmented into consumables and instruments

North America Automated Cell Cultures Market, By Type

• Infinite Cell Line Cultures
• Finite Cell Line Cultures

On the basis of type, the North America automated cell cultures market is segmented into infinine Cell line cultures and finite Cell line cultures

North America Automated Cell Cultures Market, By Application

• Drug Development
• Stem Cell Research
• Regenerative Medicine
• Cancer Research
• Vaccines
• Other

On the basis of application, the North America automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccine and other.

North America Automated Cell Cultures Market, By End User

• Biotech Companies
• Research Organizations
• Academic Research Institutes
• Other

On the basis of end user, the North America automated cell cultures market is segmented into biotech companies, research organizations, academic research institutes and other.

North America Automated Cell Cultures Market Regional Analysis/Insights

The North America automated cell cultures market is analyzed and market size information is provided by Product, Type, Application, and End User.

The countries covered in this market report are U.S., Canada, and Mexico.

In 2022, The North America automated cell cultures market is expected to grow due to increasing applications in stem cell research, vaccine production, regenerative medicines production, and drug discovery.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Automated Cell Cultures Market Share Analysis

North America automated cell cultures market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the North America automated cell cultures market.

The key market players for North America automated cell cultures market are Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, Advanced Instruments,Benchmark scientific, Inc., BioSpherix, Ltd., Biotron Healthcare, Bulldog Bio, Cell Culture Company, LLC, CellGenix GmbH, ChemoMetec, Corning Incorporated, Cytiva (Subsidiary of Danahar Corporation), FUJIFILM Holdings America Corporation, Hemilton Company, Hitachi, Ltd., Kawasaki Heavy Industries, ltd., HiMedia Laboratories, NanoEntek America, Inc., Nexcelom Bioscience LLC., PromoCell GmbH, RWD Life Science Co., LTD, Sartorius AG, Scientica Instrumentation, Inc., SHIBUYA CORPORATION, Sphere Fluidics Limited, Tecan Trading AG,Thrive Bioscience, Inc., and Others.

Research Methodology: North America Automated Cell Cultures Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, North America vs Regional, and Vendor Share Analysis. Please request analyst call in case of further inquiry.

SKU-65939